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RESULTS (cont)

ABSTRACT

RESULTS

OBJECTIVE: To estimate if cervical biopsy at the time of colposcopy changes the management or
outcome of abnormal cervical cytology during pregnancy.
STUDY DESIGN: Retrospective cohort study of pregnant women with abnormal cervical cytology (CC) who
underwent colposcopy from 2005‐08. Women who had a cervical biopsy (CBx) at the time of colposcopy
were compared to those that did not. The primary outcomes were the rates of regression, persistence, and
progression. Regression and progression were defined as ≥1 degree of difference between antepartum CC or
colpopscopy and post partum CC.
CC A multinomial regression analysis was used to control for confounding.
confounding
RESULTS: 177 pregnant women with abnormal cervical cytology were referred to colposcopy. The incidence
of ASCUS high risk HPV, LGSIL, and HGSIL cervical cytology was 41%, 52%, and 3% respectively. The
colposcopic diagnosis was CIN1 in 41%, CIN2 in 11% and CIN3 in 1%. Comparing the results of antepartum to
postpartum CC, the performance of a CBx was not associated with a significant difference in outcome (table
1, p=.825). Comparing colposcopy to post partum CC, performance of a CBx was associated with a lower rate
of progression even after controlling for age, tobacco use, previous abnormal CC, and trimester at the time of
cervical cancer screening (table 2, p=.026). No women were treated by excisional procedure and no cases of
cervical cancer were diagnosed during the study period.
CONCLUSION: Biopsy of suspected cervical lesions can be safely deferred until after pregnancy because there
were no significant changes between antepartum and postpartum CC and no missed cases of cervical cancer
were detected.

• 177 pregnant women met the inclusion criteria
• Women who had a CBx were older, more likely to have a history of ACC,
and more likely to use tobacco (table)

• Each year in the United States abnormal cervical cytology (ACC) affects
2‐7% of pregnant women (ie. 80,000‐320,000)
• 0.5‐1% will be diagnosed with cervical intraepithelial neoplasia
• Several p
published reports
p
support
pp the accuracyy of visual colposcopic
p
p
impression during pregnancy
• Perceived risks limit the number of cervical biopsies performed during
pregnancy
• By not performing a biopsy, there is a small chance:
1) of progression to invasive cancer during pregnancy
2) that invasive cancer will be missed

• Objective: to estimate if cervical biopsy (CBx) at the time of
colposcopy changes the management or outcome of ACC
during pregnancy

MATERIALS & METHODS
• Retrospective cohort study of pregnant women with ACC who underwent
colposcopy
p
py from 2005‐08
• Only women who returned for postpartum cervical cytology were
included
• Women who had CBx at time of colposcopy were compared with those
that did not
• Primary outcomes were the rates of regression
regression, persistence
persistence, and
progression
• Progression and regression were defined as ≥1 degree of difference

Demographic Variable
Age (y)
History of prior ACC

CBx (n=25)

No CBx (n=152)

p

24 (18‐39)

22 (13‐41)

.031

51 (34%)

<.001

2 (8%)

5 (3%)

.258

Tobacco use*

11 (44%)

34 (22%)

.023

HIV positive†

3 (4%)

1 (2%)

.463

History of STD

16 (64%)

91 (60%)

.695

History of excisional procedure

53%

Regression

18 (72%)

48%
32%

Persistence

37%
16%
15%

Progression

0%

10%

20%

CBx

30%

40%

No CBx

50%

60%

*data missing for 1 woman; †data missing for 9 women
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Table: Maternal demographic characteristics

FIGURE 2: Outcome rates compared by biopsy group
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• In an additional analysis, there was no difference in the rates of
regression,
i
persistence,
i
and
d progression
i comparing
i colposcopic
l
i
diagnosis to postpartum cervical cytology (p=.897)
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• There was no difference in the rates of regression, persistence, and
progression comparing antepartum to postpartum cervical cytology
( 825 d
(p=.825;
data
t nott shown)
h
)
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Figure 1: Accuracy of visual colposcopic impression
• Colposcopy was performed in the 1st, 2nd, and 3rd trimester in
14%, 62%, and 24% respectively
• The
Th iincidence
id
off hi
high‐grade
h
d cervical
i l cytology
t l
(11%) and
d cervical
i l
intraepithelial neoplasia grade 3 (3%) were low
• Figure 1 shows the final biopsy diagnosis compared to visual impression

• No women were treated by excisional procedure during
pregnancy
• No cases of cervical cancer were diagnosed by biopsy (or as a
result of post partum cervical cytology)

CONCLUSIONS
• Antepartum knowledge of cervical biopsy results did not
change the management of ACC during pregnancy
• For most pregnant women with abnormal cervical cytology, CBx
can be safely deferred until after pregnancy
• ASCCP Guideline: only when there is a suspicion of CIN2,3 or cancer
should a CBx be performed during pregnancy

• The low incidence of cervical cancer during pregnancy and small
sample size should be taken into consideration when interpreting
these results

